Shopping Cart
- Remove All
- Your shopping cart is currently empty
BY27, a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4, and BRDT, and suppresses tumor growth.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $483 | In Stock | |
2 mg | $690 | In Stock | |
5 mg | $1,080 | In Stock | |
10 mg | $1,490 | In Stock | |
25 mg | $2,190 | In Stock | |
50 mg | $2,980 | In Stock |
Description | BY27, a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4, and BRDT, and suppresses tumor growth. |
Targets&IC50 | BRD2 BD1:95.5 nM (Ki), BRD2 BD1:45 nM (Kd), BRDT BD2:3 nM (Kd), BRD2 BD2:3.1 nM (Ki), BRD2 BD2:1.2 nM (Kd), BRD4 BD2:3.5 nM (Kd), BRD4 BD2:7.3 nM (Ki), BRD3 BD2:5.3 nM (Ki), BRD3 BD2:2.6 nM (Kd), BRDT BD1:64 nM (Kd), BRD4 BD1:26 nM (Kd), BRD4 BD1:80 nM (Ki), BRD3 BD1:12 nM (Kd), BRD3 BD1:77.9 nM (Ki) |
Molecular Weight | 404.89 |
Formula | C22H21ClN6 |
Cas No. | 2247236-59-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.